- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/04 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
Patent holdings for IPC class C07D 295/04
Total number of patents in this class: 128
10-year publication summary
|
9
|
1
|
3
|
9
|
10
|
6
|
5
|
6
|
3
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19961 |
8 |
| Crinetics Pharmaceuticals, Inc. | 117 |
8 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10931 |
4 |
| Amyris, Inc. | 375 |
4 |
| ST Pharm Co., Ltd. | 83 |
4 |
| Bristol-myers Squibb Company | 4880 |
3 |
| Janssen Pharmaceutica N.V. | 3394 |
3 |
| Vanderbilt University | 1907 |
3 |
| Sanofi | 4072 |
3 |
| Bayer Schering Pharma AG | 384 |
2 |
| Chemo Research, S.L. | 100 |
2 |
| Ligand Pharmaceuticals Incorporated | 171 |
2 |
| Ono Pharmaceutical Co., Ltd. | 432 |
2 |
| Palatin Technologies, Inc. | 70 |
2 |
| Ramot at Tel-Aviv University Ltd. | 1477 |
2 |
| UDC Ireland Limited | 476 |
2 |
| Reneo Pharmaceuticals, Inc. | 21 |
2 |
| Escalier Biosciences, BV | 6 |
2 |
| Prilenia Neurotherapeutics Ltd. | 88 |
2 |
| Celltaxis, LLC | 26 |
2 |
| Other owners | 66 |